Enalaprilat and Nabumetone interaction
Enalaprilat and Nabumetone: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Enalaprilat label · effective 2024-01-04
Non-steroidal anti-inflammatory agents In some patients with compromised renal function who are being treated with non-steroidal anti-inflammatory drugs, the co-administration of enalapril may result in a further deterioration of renal function.
This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors.
However, reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors.
From the Nabumetone label · effective 2026-01-01
This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.
Use of Nabumetone may blunt the CV effects of several therapeutic agents used to treat these medical conditions [e.g., diuretics, ACE inhibitors, or angiotensin receptor blockers (ARBs)] [see Drug Interactions ] .
Drug Interactions: ACE-inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.